CXCR4 monoclonal antibodies (Northwest Biotherapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCXCR4 monoclonal antibodies (Northwest Biotherapeutics)
Drug Alias NameCXCR4 therapeutics (Northwest Biotherapeutics)CX-02 (Northwest Biotherapeutics)CX-05
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulators
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwest Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwest Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A